Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.65 M2.41 M2.87 M2.89 M 10.81 M Research & development 743 K951 K547 K1.9 M 4.14 M Operating income -3.52 M-3.49 M-3 M-4.51 M -14.52 M Non-Operating Income, Total -3.2 M-6.94 M-1.28 M-3.1 M -14.53 M Interest expense, net of interest capitalized 2.43 M—1 0000 — Non-Operating Income, excl. Interest Expenses -5.63 M-6.94 M-1.28 M-3.1 M -16.96 M Unusual income/expense ———— — Pretax income -6.72 M-10.43 M-4.29 M-7.62 M -29.05 M Equity in earnings ———— — Taxes 004 0000 4 000 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -6.72 M-10.43 M-4.29 M-7.62 M -29.06 M Discontinued operations ———— — Net income -6.72 M-10.43 M-4.29 M-7.62 M -29.06 M Dilution adjustment -1.58 M01.58 M0 0 Preferred dividends -780 K000 -780 K Diluted net income available to common stockholders -7.52 M-10.43 M-2.71 M-7.62 M -28.28 M Basic earnings per share (Basic EPS) 0.03-0.190.21-0.1 -0.05 Diluted earnings per share (Diluted EPS) 0.11-0.19-0.12-0.1 -0.3 Average basic shares outstanding -62.42 M54.45 M36.23 M74.44 M — Diluted shares outstanding -62.42 M54.45 M36.23 M74.44 M — EBITDA -3.48 M-3.42 M-2.96 M-4.46 M -14.33 M EBIT -3.52 M-3.49 M-3 M-4.51 M -14.52 M Cost of revenue 2.26 M1.32 M591 K875 K 5.04 M Other cost of goods sold ——-220 K180 K — Depreciation & amortization (cash flow) 43 K65 K40 K46 K 194 K